Joshua C. Black

544 total citations
46 papers, 356 citations indexed

About

Joshua C. Black is a scholar working on Public Health, Environmental and Occupational Health, Toxicology and Pharmacology. According to data from OpenAlex, Joshua C. Black has authored 46 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 16 papers in Toxicology and 12 papers in Pharmacology. Recurrent topics in Joshua C. Black's work include Opioid Use Disorder Treatment (26 papers), Forensic Toxicology and Drug Analysis (15 papers) and Substance Abuse Treatment and Outcomes (9 papers). Joshua C. Black is often cited by papers focused on Opioid Use Disorder Treatment (26 papers), Forensic Toxicology and Drug Analysis (15 papers) and Substance Abuse Treatment and Outcomes (9 papers). Joshua C. Black collaborates with scholars based in United States, Hong Kong and United Kingdom. Joshua C. Black's co-authors include Richard C. Dart, Janetta Iwanicki, Karilynn Rockhill, Jonathan Schimmel, Paul I. Dargan, David M. Wood, Kevin P. May, Andrew A. Monte, Richard A. Olson and Jennifer S. Jewell and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and American Journal of Public Health.

In The Last Decade

Joshua C. Black

35 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua C. Black United States 11 115 103 76 75 72 46 356
Marion A. Coe United States 7 182 1.6× 115 1.1× 74 1.0× 63 0.8× 95 1.3× 12 393
Janetta Iwanicki United States 12 172 1.5× 90 0.9× 57 0.8× 63 0.8× 66 0.9× 35 433
Hugh Claridge United Kingdom 13 82 0.7× 74 0.7× 46 0.6× 92 1.2× 58 0.8× 20 457
Christine Goodair United Kingdom 10 62 0.5× 74 0.7× 46 0.6× 73 1.0× 58 0.8× 23 388
Gregory B. Collins United States 11 73 0.6× 70 0.7× 39 0.5× 69 0.9× 65 0.9× 23 463
Karilynn Rockhill United States 11 344 3.0× 87 0.8× 63 0.8× 49 0.7× 65 0.9× 35 621
Jason M. Jerry United States 10 73 0.6× 43 0.4× 28 0.4× 89 1.2× 28 0.4× 14 455
Megan Buresh United States 12 314 2.7× 39 0.4× 32 0.4× 29 0.4× 32 0.4× 37 484
Gunilla Thelander Sweden 16 192 1.7× 153 1.5× 66 0.9× 208 2.8× 112 1.6× 20 864
Christopher D. Rosenbaum United States 8 16 0.1× 128 1.2× 62 0.8× 139 1.9× 83 1.2× 14 487

Countries citing papers authored by Joshua C. Black

Since Specialization
Citations

This map shows the geographic impact of Joshua C. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua C. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua C. Black more than expected).

Fields of papers citing papers by Joshua C. Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua C. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua C. Black. The network helps show where Joshua C. Black may publish in the future.

Co-authorship network of co-authors of Joshua C. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua C. Black. A scholar is included among the top collaborators of Joshua C. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua C. Black. Joshua C. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christine, Paul J., et al.. (2025). Comparison of heroin and fentanyl use in US nationally representative surveys. Addiction Science & Clinical Practice. 20(1). 13–13.
2.
Palamar, Joseph J., Linda B. Cottler, & Joshua C. Black. (2025). Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015–2023. The American Journal of Drug and Alcohol Abuse. 51(3). 339–348. 1 indexed citations
3.
Rockhill, Karilynn, Joshua C. Black, Janetta Iwanicki, & Alison G. Abraham. (2025). Polysubstance Use Profiles Among the General Adult Population, United States, 2022. American Journal of Public Health. 115(5). 747–757. 1 indexed citations
4.
Dart, Richard C., et al.. (2025). Motivations, perceived risk, and tampering of XTAMPZA ER and abuse-deterrent opioid drugs. PLoS ONE. 20(10). e0332574–e0332574.
5.
Palamar, Joseph J., Jennifer S. Jewell, Omar El‐Shahawy, & Joshua C. Black. (2025). Trends in poisonings involving ketamine in the United States, 2019–2023. Drug and Alcohol Dependence. 268. 112549–112549. 2 indexed citations
6.
Rockhill, Karilynn, Joshua C. Black, Jennifer S. Jewell, et al.. (2025). The Rise of Psilocybin Use in the United States: A Multisource Observational Study. Annals of Internal Medicine. 178(7). 1052–1054. 7 indexed citations
7.
Rockhill, Karilynn, et al.. (2025). Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings. Pharmacoepidemiology and Drug Safety. 34(1). e70085–e70085.
8.
Black, Joshua C., et al.. (2025). Trends in Nonfatal Fentanyl Exposures Involving Stimulants in the United States, 2015–2023. American Journal of Preventive Medicine. 69(3). 107742–107742.
9.
Black, Joshua C., Andrew A. Monte, Jennifer S. Jewell, et al.. (2024). Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance. Nature Mental Health. 2(5). 469–477. 1 indexed citations
10.
Hoyte, Christopher, et al.. (2024). Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022. Annals of Emergency Medicine. 84(6). 605–618. 5 indexed citations
11.
Black, Joshua C., et al.. (2023). Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis. Journal of Medical Internet Research. 25. e46747–e46747.
12.
Black, Joshua C., et al.. (2023). Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness. International Journal of Mental Health and Addiction. 23(2). 1179–1192. 2 indexed citations
13.
Jewell, Jennifer S., et al.. (2023). A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clinical Drug Investigation. 43(3). 197–203. 2 indexed citations
14.
Rockhill, Karilynn, Richard A. Olson, Richard C. Dart, Janetta Iwanicki, & Joshua C. Black. (2023). Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. Journal of Medical Internet Research. 25. e46742–e46742. 1 indexed citations
15.
Black, Joshua C., Karilynn Rockhill, Richard C. Dart, & Janetta Iwanicki. (2022). Clustering patterns in polysubstance mortality in the United States in 2017: a multiple correspondence analysis of death certificate data. Annals of Epidemiology. 77. 119–126. 4 indexed citations
16.
Black, Joshua C., et al.. (2021). Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study. JMIR Public Health and Surveillance. 7(12). e29187–e29187. 6 indexed citations
17.
Black, Joshua C., S. Geoff Severtson, Karilynn Rockhill, et al.. (2021). Drug product dispensing and estimates of use in a general population survey as a signal detection problem. Pharmacoepidemiology and Drug Safety. 30(8). 1132–1139. 8 indexed citations
18.
Black, Joshua C., et al.. (2020). Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study. JMIR Public Health and Surveillance. 6(2). e17073–e17073. 13 indexed citations
19.
Black, Joshua C., et al.. (2019). An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study. Journal of Medical Internet Research. 21(10). e15830–e15830. 30 indexed citations
20.
Webb, Neil, et al.. (2019). Non-medical use of loperamide in the UK and the USA. QJM. 113(1). 25–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion A. Coe Breakdown of academic impact, for papers by Janetta Iwanicki Breakdown of academic impact, for papers by Hugh Claridge Breakdown of academic impact, for papers by Christine Goodair Breakdown of academic impact, for papers by Gregory B. Collins Breakdown of academic impact, for papers by Karilynn Rockhill Breakdown of academic impact, for papers by Jason M. Jerry Breakdown of academic impact, for papers by Megan Buresh Breakdown of academic impact, for papers by Gunilla Thelander Breakdown of academic impact, for papers by Christopher D. Rosenbaum
Rankless by CCL
2026